Another positive development for Lilly's weight-loss portfolio, with the company reporting positive results from its Phase 3 trial of a once-daily oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist. …
Lilly records another win in weight loss in trial of oral GLP-1 agonist
April 22, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News -
Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells
May 12, 2025 - -
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 - - Australian Biotech -
An already busy fixed ministerial bandwidth, just got much busier
May 12, 2025 - - Latest News -
Australia has been managing the risk of international reference pricing for most of this century
May 11, 2025 - - Latest News